These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 10982066)

  • 1. Induction of immunological memory in UK infants by a meningococcal A/C conjugate vaccine.
    Borrow R; Fox AJ; Richmond PC; Clark S; Sadler F; Findlow J; Morris R; Begg NT; Cartwright KA
    Epidemiol Infect; 2000 Jun; 124(3):427-32. PubMed ID: 10982066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of immunologic memory by conjugated vs plain meningococcal C polysaccharide vaccine in toddlers: a randomized controlled trial.
    MacDonald NE; Halperin SA; Law BJ; Forrest B; Danzig LE; Granoff DM
    JAMA; 1998 Nov; 280(19):1685-9. PubMed ID: 9832000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and immunogenicity of a booster dose of meningococcal (groups A, C, W, and Y) polysaccharide diphtheria toxoid conjugate vaccine.
    Robertson CA; Greenberg DP; Hedrick J; Pichichero M; Decker MD; Saunders M
    Vaccine; 2016 Oct; 34(44):5273-5278. PubMed ID: 27642132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety, immunogenicity, and induction of immunologic memory by a serogroup C meningococcal conjugate vaccine in infants: A randomized controlled trial.
    MacLennan JM; Shackley F; Heath PT; Deeks JJ; Flamank C; Herbert M; Griffiths H; Hatzmann E; Goilav C; Moxon ER
    JAMA; 2000 Jun; 283(21):2795-801. PubMed ID: 10838647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized study comparing the safety and immunogenicity of a conjugate vaccine combination containing meningococcal group C and pneumococcal capsular polysaccharide--CRM197 with a meningococcal group C conjugate vaccine in healthy infants: challenge phase.
    Riddell A; Buttery JP; McVernon J; Chantler T; Lane L; Bowen-Morris J; Diggle L; Morris R; Lockhart S; Pollard AJ; Cartwright K; Moxon ER
    Vaccine; 2007 May; 25(19):3906-12. PubMed ID: 17368663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is a single infant priming dose of meningococcal serogroup C conjugate vaccine in the United Kingdom sufficient?
    Findlow H; Borrow R
    Hum Vaccin Immunother; 2015; 11(6):1501-6. PubMed ID: 25912095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and immunogenicity of a serogroups A/C Neisseria meningitidis oligosaccharide-protein conjugate vaccine in young children. A randomized controlled trial.
    Lieberman JM; Chiu SS; Wong VK; Partidge S; Chang SJ; Chiu CY; Gheesling LL; Carlone GM; Ward JI
    JAMA; 1996 May; 275(19):1499-503. PubMed ID: 8622225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of prior polysaccharide vaccination on magnitude, duration, and quality of immune responses to and safety profile of a meningococcal serogroup C tetanus toxoid conjugate vaccination in adults.
    Southern J; Deane S; Ashton L; Borrow R; Goldblatt D; Andrews N; Balmer P; Morris R; Kroll JS; Miller E
    Clin Diagn Lab Immunol; 2004 Nov; 11(6):1100-4. PubMed ID: 15539513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Priming for immunologic memory in adults by meningococcal group C conjugate vaccination.
    Vu DM; de Boer AW; Danzig L; Santos G; Canty B; Flores BM; Granoff DM
    Clin Vaccine Immunol; 2006 Jun; 13(6):605-10. PubMed ID: 16760316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dosage escalation, safety and immunogenicity study of four dosages of a tetravalent meninogococcal polysaccharide diphtheria toxoid conjugate vaccine in infants.
    Rennels M; King J; Ryall R; Papa T; Froeschle J
    Pediatr Infect Dis J; 2004 May; 23(5):429-35. PubMed ID: 15131466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salivary antibodies following parenteral immunization of infants with a meningococcal serogroup A and C conjugated vaccine.
    Borrow R; Fox AJ; Cartwright K; Begg NT; Jones DM
    Epidemiol Infect; 1999 Oct; 123(2):201-8. PubMed ID: 10579438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meningococcal serogroup C conjugate vaccine is immunogenic in infancy and primes for memory.
    Richmond P; Borrow R; Miller E; Clark S; Sadler F; Fox A; Begg N; Morris R; Cartwright K
    J Infect Dis; 1999 Jun; 179(6):1569-72. PubMed ID: 10228085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of immunologic memory in Gambian children by vaccination in infancy with a group A plus group C meningococcal polysaccharide-protein conjugate vaccine.
    Leach A; Twumasi PA; Kumah S; Banya WS; Jaffar S; Forrest BD; Granoff DM; LiButti DE; Carlone GM; Pais LB; Broome CV; Greenwood BM
    J Infect Dis; 1997 Jan; 175(1):200-4. PubMed ID: 8985221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conjugate meningococcal serogroup A and C vaccine: reactogenicity and immunogenicity in United Kingdom infants.
    Fairley CK; Begg N; Borrow R; Fox AJ; Jones DM; Cartwright K
    J Infect Dis; 1996 Dec; 174(6):1360-3. PubMed ID: 8940235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of antibody kinetics following meningococcal serogroup C conjugate vaccine between healthy adults previously vaccinated with meningococcal A/C polysaccharide vaccine and vaccine-naïve controls.
    Borrow R; Southern J; Andrews N; Peake N; Rahim R; Acuna M; Martin S; Miller E; Kaczmarski E
    Vaccine; 2001 Apr; 19(23-24):3043-50. PubMed ID: 11311998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meningococcal group C and w135 immunological hyporesponsiveness in african toddlers.
    Findlow H; Sow S; Borrow R; Tapia M; Haidara FC; Akinsola AK; Idoko OT; Diallo F; Adegbola R; Tang Y; Parulekar V; Chadha H; Mabey L; Holme D; Townsend K; Chaumont J; Laforce FM; Kulkarni PS; Marchetti E; Viviani S; Hassan-King M; Preziosi MP
    Clin Vaccine Immunol; 2011 Sep; 18(9):1492-6. PubMed ID: 21752951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response of 7- to 15-month-old infants to sequential immunization with Haemophilus influenzae type b-CRM197 conjugate and polysaccharide vaccines.
    Rothstein EP; Schiller RP; Girone JA; Hipp TJ; Souder RL; Bernstein HH; Madore DV; Johnson CL; Smith DH
    Am J Dis Child; 1991 Aug; 145(8):898-900. PubMed ID: 1858727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between serum bactericidal activity and serogroup-specific immunoglobulin G concentration for adults, toddlers, and infants immunized with Neisseria meningitidis serogroup C vaccines.
    Sikkema DJ; Friedman KE; Corsaro B; Kimura A; Hildreth SW; Madore DV; Quataert SA
    Clin Diagn Lab Immunol; 2000 Sep; 7(5):764-8. PubMed ID: 10973451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune memory in children previously vaccinated with an experimental quadrivalent meningococcal polysaccharide diphtheria toxoid conjugate vaccine.
    Pichichero M; Papa T; Blatter M; Mitchell D; Kratz R; Sneed J; Bassily E; Casey J; Gilmet G
    Pediatr Infect Dis J; 2006 Nov; 25(11):995-1000. PubMed ID: 17072120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and immunogenicity of meningococcus serogroup C conjugate vaccine administered as a primary or booster vaccination to healthy four-year-old children.
    McVernon J; Maclennan J; Buttery J; Oster P; Danzig L; Moxon ER
    Pediatr Infect Dis J; 2002 Aug; 21(8):747-53. PubMed ID: 12192163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.